LINK Medical appoints Sissel Lønning Andresen as CEO

The LINK Medical Board has announced the appointment of Sissel Lønning Andresen as the company’s new CEO.

Andresen will assume the position of CEO on January 1, 2023.

Ola Gudmundsen will remain with the company in a strategic role where he will work closely with Andresen and support the Business Development and Commercial Operations team.

Gudmundsen will remain an important owner of the company and continue to serve on the board of LINK Medical, the company said.LINK Medical chairman, Michael Bodd, said:

“I’m delighted to welcome Sissel as the new CEO of LINK Medical.

“We look forward to the next phase of LINK’s development under Sissel’s leadership.

“She has an impressive track record and will contribute with comprehensive industry knowledge and build on our existing strengths, to accelerate growth and profitability in our key business areas.”

Andresen joins LINK Medical from Pfizer Norway, where she was CEO for nine years.

She previously held a number of roles at Pfizer and has also worked at Pharmacia and GE Healthcare.

Sissel Lønning Andresen said:

“I’m thrilled and humbled to start the role as new CEO of LINK Medical at such a pivotal time and look forward to meeting my new colleagues across all departments.

“LINK has a great reputation for delivering high-quality services to the life science industry, and together with the highly skilled staff we will build and develop the company into its next chapter of growth.”

Ola Gudmundsen added:

“I’m confident that Sissel will lead LINK Medical forward into the next phase of development.

“Sissel will further strengthen LINK Medical’s position as the leading Northern European CRO and capture the many exciting opportunities ahead of us.”